Surveillance infrastructure is essential to address antimicrobial resistance in the Americas

Lancet Reg Health Am. 2023 Dec 21:29:100654. doi: 10.1016/j.lana.2023.100654. eCollection 2024 Jan.

Eduardo A Undurraga^{1

2

3

4}, Anne Peters^{1

5}, Cesar A Arias^{6

7

8}, Jose M Munita^{1

5}

¹ Multidisciplinary Initiative for Collaborative Research on Bacterial Resistance (MICROB-R), Chile.
² Escuela de Gobierno, Pontificia Universidad Católica de Chile, Chile.
³ Centro de Investigación para la Gestión Integrada del Riesgo de Desastres (CIGIDEN), Chile.
⁴ Canadian Institute for Advanced Research (CIFAR) Azrieli Global Scholars Program, Toronto, Canada.
⁵ Genomics and Resistant Microbes (GeRM), Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
⁶ Division of Infectious Diseases, Houston Methodist Hospital, TX, USA.
⁷ Center for Infectious Diseases, Houston Methodist Research Institute, Houston, TX, USA.
⁸ Department of Medicine, Weill Cornell Medical College, New York, NY, USA.

No abstract available